Notalvision (Israel) Pfizer Incorporated (USA) Pharmalef (Israel) Ilypsa (USA) Merck Frosst (USA/Canada) ClinTec International (UK) Metrics Research (Pakistan) Appolo Hospitals (India) Tissue Regineration (USA) Anaborex (USA) Farmed Pharmaceuticals Inc (Turkey) Covansys (India) Aphasa (Russia) Ethica Clinical Research Inc. (Quebec, Canada) IntelliPharmaCeutics Corp (Canada) MIGENIX Inc. (Canada) Panacea Biotec (India) Takeda Pharmaceuticals (USA) SPRI (Ukraine) ProSolution (UK) Alcon (Canada) Anestvice (Russia) Cereprotec (USA) Mirabilis Medica Inc. (USA) TrialStat (Canada) Massachusetts General Hospital (USA) Pharmaxis (Australia) General Hospital of Massachusetts

CRO Products and Services

Clinical Trials


Therapeutic Areas: Oncology | Neurology

Glioblastoma multiforme Clinical Trials


A listing of Glioblastoma multiforme medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : University of Alabama at Birmingham

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

Birmingham : University of Alabama at Birmingham

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

Birmingham : University of Alabama at Birmingham

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Arizona

Phoenix : Barrow Neurology Clinics

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Scottsdale : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Arkansas

Fayetteville : Highlands Oncology Group Highlands

Patients are needed to participate in a clinical research study of BKM120 + temozolomide and BKM120 +temozolomide with/without radiotherapy to evaluate Glioblastoma

Little Rock : University of Arkansas for Medical Sciences

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

California

Castro Valley : Sutter East Bay Neuroscience Institute-Eden Medical Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Duarte : City of Hope Updated

A clinical trial to evaluate treatments using Toca 511 and 5-FC for patients with Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

Duarte : City of Hope

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Duarte : City of Hope

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Duarte : City of Hope

Patients are needed to participate in a clinical research study evaluating I-124-CLR1404 for the treatment of Glioblastoma Multiforme

Fullerton : St. Jude's Medical Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Irvine : UCI Medical Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

La Jolla : University of California San Diego Moores Cancer Center (UCSD)

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Los Angeles : Cedars-Sinai Medical Center

A clinical trial to evaluate treatments using CC-115 for patients

Los Angeles : UCLA Updated

A clinical trial to evaluate treatments using Toca 511 and 5-FC for patients with Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

Los Angeles : UCLA Updated

A clinical trial to evaluate treatments using Toca 511 for patients with Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

Los Angeles : Research Site

A Phase 1 clinical study for patients with Advanced Malignant Glioma, Anaplastic Astrocytomas or Glioblastoma Multiforme

Los Angeles : University of Southern California (USC)

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Los Angeles : UCLA

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Los Angeles : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Los Angeles : University of California, Los Angeles

Patients are needed to participate in a clinical research study of AQ4N, Temozolomide and Radiotherapy to evaluate Glioblastoma Multiforme

Los Angeles : Cedars-Sinai Medical Center-Samuel Oschin Comprehensive Cancer Institute

Patients are needed to participate in a clinical research study of CC-223

Los Angeles : UCLA

Patients are needed to participate in a clinical research study of Toca 511 to evaluate Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

Newport Beach : Hoag Memorial Hospital Presbyterian

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Orange : St. Joseph Hospital of Orange

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Orange : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Sacramento : Sutter Institute for Medical Research

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

San Diego : UCSD Updated

A clinical trial to evaluate treatments using Toca 511 and 5-FC for patients with Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

San Diego : University of California at San Diego

Patients are needed to participate in a clinical research study of Toca 511 to evaluate Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

San Francisco : University of California at San Francisco

A clinical trial to evaluate treatments using CC-115 for patients

San Francisco : UCSF Updated

A clinical trial to evaluate treatments using Toca 511 and 5-FC for patients with Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

San Francisco : The Regents of the University of California

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

San Francisco : University of California at San Francisco

Patients are needed to participate in a clinical research study of CC-223

San Francisco : University of California, San Francisco, Division of Neuro-Oncology

Patients are needed to participate in a clinical research study of VAL-083

South Pasadena : South Pasadena Cancer Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Stanford : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Colorado

Aurora : University of Colorado Denver

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Aurora : University of Colorado Cancer Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Connecticut

New Haven : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

New Haven : Yale School of Medicine

Patients are needed to participate in a clinical research study of Bevacizumab and BKM120 to evaluate Glioblastoma Multiforme

District of Columbia

Washington : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Florida

Fort Myers : Florida Cancer Specialists

Patients are needed to participate in a clinical research study of Bevacizumab and BKM120 to evaluate Glioblastoma Multiforme

Hollywood : Memorial Cancer Institute

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Miami Beach : Mount Sinai CCOP

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Miami Beach : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Orlando : UF Health Cancer Center at Orlando Health

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Orlando : Florida Hospital Cancer Institute

Patients are needed to participate in a clinical research study of Bevacizumab and BKM120 to evaluate Glioblastoma Multiforme

Pensacola : Woodlands Medical Specialists

Patients are needed to participate in a clinical research study of Bevacizumab and BKM120 to evaluate Glioblastoma Multiforme

Sarasota : Florida Cancer Specialists

Patients are needed to participate in a clinical research study of VAL-083

St. Petersburg : Florida Cancer Specialists

Patients are needed to participate in a clinical research study of Bevacizumab and BKM120 to evaluate Glioblastoma Multiforme

Tampa : H Lee Moffitt Cancer Center and Research Institute, Inc.

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

Tampa : Moffitt Cancer Center & Research Institute

A clinical trial to evaluate treatments using CC-115 for patients

Tampa : H. Lee Moffitt Cancer Center & Research Institute

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Tampa : Moffit Cancer Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Tampa : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Tampa : Moffitt Cancer Center & Research Institute

Patients are needed to participate in a clinical research study of CC-223

Georgia

Atlanta : Emory University, Winship Cancer Institute

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Atlanta : Piedmont Atlanta Hospital

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Augusta : Georgia Regents University

A clinical research study of Indoximod and Temozolomide for the treatment of Glioblastoma Multiforme, Glioma, Gliosarcoma or Malignant Brain Tumor

Augusta : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Illinois

Chicago : Northwestern Medical Faculty Foundation

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

Chicago : Ann & Robert H. Lurie Children's Hospital of Chicago (Formerly Children's Memorial Hospital)

A clinical trial seeking patients for a research study for the treatment of Malignant Glioma or Recurrent Ependymoma

Chicago : University of Illinois at Chicago (UIC)

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Chicago : Site Reference ID/Investigator# 106817

Patients are needed to participate in a clinical research study evaluating ABT-414, Temozolomide and Whole Brain Radiation for the treatment of Glioblastoma Multiforme

Chicago : Rush University Medical Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Chicago : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Chicago : Northwestern University Feinberg School of Medicine

Patients are needed to participate in a clinical research study of AQ4N, Temozolomide and Radiotherapy to evaluate Glioblastoma Multiforme

Evanston : Site Reference ID/Investigator# 106816

Patients are needed to participate in a clinical research study evaluating ABT-414, Temozolomide and Whole Brain Radiation for the treatment of Glioblastoma Multiforme

Peoria : Illinois Cancer Care

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Warrenville : Central DuPage Cancer Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Indiana

Indianapolis : IU Simon Cancer Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Kansas

Westwood : KU Medical Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Kentucky

Lexington : University of Kentucky, Markey Cancer Center

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Louisville : Norton Cancer Institute

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Louisiana

New Orleans : Tulane University

Patients are needed to participate in a clinical research study evaluating 4-Demethyl-4-cholestryloxycarbonylpenclomedine for the treatment of Primary Brain Tumors or Secondary Brain Tumors

Maine

Scarborough : Maine Medical Center

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Maryland

Baltimore : The Johns Hopkins Hospital

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Baltimore : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Bethesda : Center for Cancer and Blood Disorders

Patients are needed to participate in a clinical research study of Bevacizumab and BKM120 to evaluate Glioblastoma Multiforme

Massachusetts

Boston : Brigham and Women's Hospital

A clinical research study of FLT-PET/CT: (3'deoxy-3'-[(18)F] fluorothymidine) PET/CT for the treatment of High Grade Glioma

Boston : Dana Farber Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Glioblastoma Multiforme

Boston : Dana-Farber Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Malignant Glioma or Recurrent Ependymoma

Boston : Research Site

A Phase 1 clinical study for patients with Advanced Malignant Glioma, Anaplastic Astrocytomas or Glioblastoma Multiforme

Boston : Dana-Farber Cancer Institute

A Phase 2 clinical study for patients with Glioblastoma, GBM or Glioblastoma Multiforme

Boston : Massachusetts General Hospital

A Phase 2 clinical study for patients with Glioblastoma, GBM or Glioblastoma Multiforme

Boston : Tufts Medical Center

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Boston : Site Reference ID/Investigator# 127615

Patients are needed to participate in a clinical research study evaluating ABT-414, Temozolomide and Whole Brain Radiation for the treatment of Glioblastoma Multiforme

Boston : Site Reference ID/Investigator# 95737

Patients are needed to participate in a clinical research study evaluating ABT-414, Temozolomide and Whole Brain Radiation for the treatment of Glioblastoma Multiforme

Boston : Beth Israel Deaconess Medical Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Boston : Dana-Farber Cancer Institute

Patients are needed to participate in a clinical research study of Amgen 386 and Bevacizumab to evaluate Glioblastoma Multiforme

Boston : Massachusetts General Hosptial

Patients are needed to participate in a clinical research study of Amgen 386 and Bevacizumab to evaluate Glioblastoma Multiforme

Boston : Dana Farber Cancer Institute SC (1)

Patients are needed to participate in a clinical research study of BKM120 + temozolomide and BKM120 +temozolomide with/without radiotherapy to evaluate Glioblastoma

Burlington : Lahey Clinic Medical Center

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Michigan

Ann Arbor : The Regents of the University of Michigan

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Ann Arbor : University of Michigan, Department of Neurosurgery

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Ann Arbor : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Detroit : Henry Ford Hospital Updated

A clinical trial to evaluate treatments using Toca 511 and 5-FC for patients with Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

Detroit : Henry Ford Hospital Updated

A clinical trial to evaluate treatments using Toca 511 for patients with Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

Detroit : Henry Ford Hospital

A Phase 2 clinical study for patients with Glioblastoma, GBM or Glioblastoma Multiforme

Detroit : Henry Ford Health System

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Detroit : Henry Ford Hospital

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Detroit : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Detroit : Henry Ford Health Systems

Patients are needed to participate in a clinical research study of AQ4N, Temozolomide and Radiotherapy to evaluate Glioblastoma Multiforme

Detroit : Henry Ford Hospital

Patients are needed to participate in a clinical research study of Toca 511 to evaluate Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

Grand Rapids : Grand Rapids Oncology Program

Patients are needed to participate in a clinical research study of Bevacizumab and BKM120 to evaluate Glioblastoma Multiforme

Minnesota

Minneapolis : John Nasseff Neuroscience Institute

A clinical research study of Indoximod and Temozolomide for the treatment of Glioblastoma Multiforme, Glioma, Gliosarcoma or Malignant Brain Tumor

Minneapolis : John Nasseff Neuroscience Institute

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Missouri

Chesterfield : St. Louis Cancer Care

Patients are needed to participate in a clinical research study of Bevacizumab and BKM120 to evaluate Glioblastoma Multiforme

Kansas City : St. Luke's Hospital

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

St. Louis : Washington University, School of Medicine

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

St. Louis : Washington University School of Medicine, Division of Oncology

A Phase 3 clinical study for patients with Glioblastoma Multiforme

St. Louis : Washington University School of Medicine

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Nebraska

Omaha : Nebraska Methodist Hospital

Patients are needed to participate in a clinical research study of Bevacizumab and BKM120 to evaluate Glioblastoma Multiforme

Nevada

Las Vegas : Comprehensive Cancer Centers of Nevada

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

New Jersey

Edison : New Jersey Neuroscience Center - JFK Medical Center

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Edison : JFK Medical Center

Patients are needed to participate in a clinical research study of Toca 511 to evaluate Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

Hackensack : Hackensack University Medical Center Updated

A clinical trial to evaluate treatments using Toca 511 and 5-FC for patients with Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Hackensack : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Hackensack : John Theurer Cancer Center at Hackensack University

Patients are needed to participate in a clinical research study of CC-223

New Brunswick : The Cancer Institute of New Jersey

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

New York

Manhasset : Biomedical Research Alliance of New York

Glioblastoma Multiforme (Brain Cancer) - Adults

Commack : The Long Island Brain Tumor Center at Neurological Surgery, P.C.

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

Huntington : Huntington Hospital

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Lake Success : The Long Island Brain Tumor Center at Neurological Surgery, P.C.

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

Lake Success : Long Island Brain Tumor Centre at Neurological Surgery P.C.

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Manhasset : North Shore University Hospital

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Mineola : Winthrop University Hospital

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

New York : Memorial Sloan-Kettering Cancer Center

A clinical trial to evaluate treatments using CC-115 for patients

New York : The New York Hospital/ Weill Medical College

A Phase 1/Phase 2 clinical study for patients with Glioblastoma Multiforme or Anaplastic Astrocytoma

New York : Mount Sinai Medical Center, Department of Neurosurgery

A Phase 3 clinical study for patients with Glioblastoma Multiforme

New York : Weill Cornell Medical College

A Phase 3 clinical study for patients with Glioblastoma Multiforme

New York : Site Reference ID/Investigator# 92313

Patients are needed to participate in a clinical research study evaluating ABT-414, Temozolomide and Whole Brain Radiation for the treatment of Glioblastoma Multiforme

New York : Columbia University Medical Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

New York : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

New York : NYU Cancer Institute

Patients are needed to participate in a clinical research study of CC-223

Oceanside : South Nassau Community Hospital

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Rochester : University of Rochester Medical Center

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

Rochester : University of Rochester Medical Center

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

Rochester : University of Rochester Medical Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Rockville Centre : Mercy Medical Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Stony Brook : Stony Brook University Hospital

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

White Plains : Brain and Spine Surgeons of New York and Northern Westchester Hospital

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

North Carolina

Chapel Hill : University of North Carolina

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Chapel Hill : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Durham : Duke University Medical Center

A clinical trial seeking patients for a research study for the treatment of Glioblastoma Multiforme

Durham : Duke University Medical Center

Patients are needed to participate in a clinical research study of AQ4N, Temozolomide and Radiotherapy to evaluate Glioblastoma Multiforme

Ohio

Cincinnati : University of Cincinnati

A clinical trial to evaluate treatments using Axitinib and Radiation Therapy for patients with Glioblastoma Multiforme

Cincinnati : Research Site

A Phase 1 clinical study for patients with Advanced Malignant Glioma, Anaplastic Astrocytomas or Glioblastoma Multiforme

Cincinnati : University of Cincinnati

Patients are needed to participate in a clinical research study evaluating BEZ235 and Everolimus for the treatment of Cancer

Cincinnati : UC Cancer Institute

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Cleveland : Cleveland Clinic Foundation Updated

A clinical trial to evaluate treatments using Toca 511 and 5-FC for patients with Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

Cleveland : Cleveland Clinic Foundation Updated

A clinical trial to evaluate treatments using Toca 511 for patients with Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

Cleveland : Cleveland Clinic

A Phase 2 clinical study for patients with Glioblastoma, GBM or Glioblastoma Multiforme

Cleveland : Cleveland Clinic Taussig Cancer Center

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Cleveland : University Hospitals of Cleveland

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Cleveland : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Cleveland : Cleveland Clinic Foundation

Patients are needed to participate in a clinical research study of Toca 511 to evaluate Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

Columbus : The Ohio State University Arthur G. James Cancer Hospital and Solove Research Institute

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Columbus : Ohio State University

Patients are needed to participate in a clinical research study of Toca 511 to evaluate Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

Oregon

Portland : Providence Cancer Center

A Phase 1 clinical study for patients with Astrocytic Tumors, Glioblastoma Multiforme, Anaplastic Astrocytoma or Brain Tumor

Portland : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Pennsylvania

Danville : Geisinger Health System

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Danville : Geisinger Medical Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Philadelphia : Pennsylvania Hospital

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Philadelphia : Hospital of the University of Pennsylvania

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Philadelphia : Temple University School of Medicine

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Philadelphia : Hospital of the University of Pennsylvania

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Philadelphia : Hospital of University of Pennsylvania

Patients are needed to participate in a clinical research study evaluating I-124-CLR1404 for the treatment of Glioblastoma Multiforme

Philadelphia : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Pittsburgh : University of Pittsburgh Medical Center Updated

A clinical trial to evaluate treatments using Toca 511 and 5-FC for patients with Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

Pittsburgh : University of Pittsburgh Medical Center (UPMC)

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Rhode Island

Providence : Rhode Island Hospital

A clinical research study of PSMA ADC for the treatment of GBM, Glioblastoma Multiforme or Gliosarcoma

Providence : Rhode Island Hospital

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

South Carolina

Charleston : Medical University of South Carolina

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Charleston : Medical University of South Carolina Hospitals and Clinics

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Tennessee

Nashville : Sarah Cannon Research Institute (SCRI) Drug Development Unit

A clinical trial to evaluate treatments using CC-115 for patients

Nashville : Greenville Hospital System

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Nashville : Sarah Cannon Research Institute Tennessee Oncology Drug Development Unit

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Nashville : St. Thomas Hospital

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Nashville : Vanderbilt Ingram Cancer Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Nashville : Tennessee Oncology

Patients are needed to participate in a clinical research study of Bevacizumab and BKM120 to evaluate Glioblastoma Multiforme

Nashville : Sarah Cannon Research Institute (SCRI)

Patients are needed to participate in a clinical research study of CC-223

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study of VAL-083

Texas

Dallas : Mary Crowley Cancer Research Centers

A clinical trial to evaluate treatments using CC-115 for patients

Dallas : Texas Oncology

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Dallas : UT Southwestern Medical Center

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Dallas : Baylor

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Dallas : Baylor Research Institute

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Dallas : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Dallas : Baylor Research Institute

Patients are needed to participate in a clinical research study of AQ4N, Temozolomide and Radiotherapy to evaluate Glioblastoma Multiforme

Dallas : Mary Crowley Cancer Research Centers

Patients are needed to participate in a clinical research study of CC-223

Houston : Memorial Hermann Hospital

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

Houston : Memorial Hermann Hospital

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

Houston : The University of Texas, MD Anderson Cancer Center

A clinical trial to evaluate treatments using CC-115 for patients

Houston : The Methodist Hospital Research Institute Updated

A clinical trial to evaluate treatments using Toca 511 and 5-FC for patients with Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma or Anaplastic Oligoastrocytoma

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using Vorinostat and Bevacizumab for patients with Brain Cancer

Houston : UT MD Anderson Cancer Center

A Phase 1/Phase 2 clinical study for patients with Brain Neoplasms or Central Nervous System Neoplasms

Houston : The University of Texas Health Science Center at Houston (UTHSC)

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Houston : Methodist Neurological Institute

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Houston : Methodist Hospital

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Houston : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Houston : University of Texas/MD Anderson Cancer Center MD Anderson DeGrout

Patients are needed to participate in a clinical research study of BKM120 + temozolomide and BKM120 +temozolomide with/without radiotherapy to evaluate Glioblastoma

San Antonio : Uthsc- Ctrc

A clinical trial seeking patients for a research study for the treatment of Glioblastoma Multiforme

San Antonio : South Texas Accelerated Research Therapeutics, LLC (START)

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

San Antonio : Site Reference ID/Investigator# 90773

Patients are needed to participate in a clinical research study evaluating ABT-414, Temozolomide and Whole Brain Radiation for the treatment of Glioblastoma Multiforme

San Antonio : Cancer Therapy & Research at University of Texas Health Science Center San Antonio

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

San Antonio : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Temple : Scott and White Healthcare

A Phase 3 clinical study for patients with Glioblastoma Multiforme

The Woodlands : Memorial Hermann The Woodlands

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Utah

Salt Lake City : Huntsman Cancer Center

A clinical research study of Indoximod and Temozolomide for the treatment of Glioblastoma Multiforme, Glioma, Gliosarcoma or Malignant Brain Tumor

Salt Lake City : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Virginia

Charlottesville : University of Virginia Health System

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

Charlottesville : University of Virginia Health System

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Fairfax : Virginia Cancer Specialists

A clinical research study of Indoximod and Temozolomide for the treatment of Glioblastoma Multiforme, Glioma, Gliosarcoma or Malignant Brain Tumor

Washington

Tacoma : MultiCare Health System

A Phase 2 Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain

Seattle : Swedish Neuroscience Institute

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

Seattle : Swedish Neuroscience Institute

A clinical research study of TPI 287 and Bevacizumab for the treatment of Glioblastoma Multiforme

Seattle : University of Washington/Seattle Cancer Care Alliance

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Seattle : Swedish Neuroscience Institute

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Seattle : Swedish Hospital Neuroscience Research

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Yakima : North Star Lodge Cancer Center

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

West Virginia

Morgantown : West Virginia University - Clinical Trials Research Unit

A221101 - A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients with Glioblastoma Multiforme

Wisconsin

Madison : University of Wisconsin

Patients are needed to participate in a clinical research study evaluating I-124-CLR1404 for the treatment of Glioblastoma Multiforme

Milwaukee : Aurora Saint Luke's Medical Center

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Australia

Heidelberg : Site Reference ID/Investigator# 90833

Patients are needed to participate in a clinical research study evaluating ABT-414, Temozolomide and Whole Brain Radiation for the treatment of Glioblastoma Multiforme

Melbourne : Nucleus Network

A Phase 1 and Phase 2 clinical study for patients with Glioblastoma Multiforme

Parkville : Research Site

A Phase 1 clinical study for patients with Advanced Malignant Glioma, Anaplastic Astrocytomas or Glioblastoma Multiforme

Parkville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of BKM120 + temozolomide and BKM120 +temozolomide with/without radiotherapy to evaluate Glioblastoma

Sydney : Royal North Shore Hospital

A clinical trial to evaluate treatments using Cilengitide for patients with Newly Diagnosed Non Methylated Glioblastoma Multiforme Grade 4

Austria

Feldkirch : Landeskrankenhaus Feldkirch

A clinical research study of Trivax, Temozolomide, Surgery, Radiotherapy and Temozolomide, Surgery, Radiotherapy for the treatment of Glioblastoma Multiforme

Graz : University Hospital Graz

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Innsbruck : Medical University Innsbruck

A clinical research study of Trivax, Temozolomide, Surgery, Radiotherapy and Temozolomide, Surgery, Radiotherapy for the treatment of Glioblastoma Multiforme

Linz : Landesnervenklinik Wagner-Jauregg

A clinical research study of Trivax, Temozolomide, Surgery, Radiotherapy and Temozolomide, Surgery, Radiotherapy for the treatment of Glioblastoma Multiforme

Vienna : Kaiser Franz-Josef Spital

A clinical research study of Trivax, Temozolomide, Surgery, Radiotherapy and Temozolomide, Surgery, Radiotherapy for the treatment of Glioblastoma Multiforme

Vienna : Medical University Vienna

A clinical research study of Trivax, Temozolomide, Surgery, Radiotherapy and Temozolomide, Surgery, Radiotherapy for the treatment of Glioblastoma Multiforme

Vienna : Donauspital, SMZ-Ost

A clinical research study of Trivax, Temozolomide, Surgery, Radiotherapy and Temozolomide, Surgery, Radiotherapy for the treatment of Glioblastoma Multiforme

Vienna : SMZ-Süd/Kaiser-Franz-Josef-Spital

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Vienna : Medical University of Vienna

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Belgium

Brussel : UZ Brussel

Patients are needed to participate in a clinical research study of axitinib and Axitinib plus Lomustine to evaluate Glioblastoma Multiforme

Leuven : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Liege : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Canada

Calgary : Tom Baker Cancer Center

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Hamilton : Novartis Investigative Site

Patients are needed to participate in a clinical research study of BKM120 + temozolomide and BKM120 +temozolomide with/without radiotherapy to evaluate Glioblastoma

Hamilton, : Juravinski Cancer Centre

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Montreal : Montreal Neurological Institute

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Montreal : Notre-Dame Hospital (CHUM)

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Montreal : McGill - Gerald Bronfman Centre for Clinical Research in Oncology -

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Montreal : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Ottawa : The Ottawa Hospital Cancer Centre

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Sherbrooke : (CHUS) Centre Hospitalier Universitaire de Sherbrooke, Service de Neurochirurgie

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Toronto : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Toronto : Novartis Investigative Site

Patients are needed to participate in a clinical research study of BKM120 + temozolomide and BKM120 +temozolomide with/without radiotherapy to evaluate Glioblastoma

Winnipeg : CancerCare Manitoba

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Czech Republic

Prague : Na Homolce Hospital

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Denmark

Copenhagen : Department of Oncology, Rigshospitalet

A clinical research study of ALECSAT and Bevacizumab/Irinotecan for the treatment of Glioblastoma Multiforme

France

Amiens : CHU Amiens Sud-Salouel

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Angers : CHU Angers

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Bordeaux : Hôpital Saint André Centre Hospitalier Universitaire (CHU) des Hôpitaux de Bordeaux

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Clichy : CHU Clemenceau

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Lyon : Hospital of Neurology Pierre Wertheimer

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Marseille : IPC

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Paris : Group Hospitals Pitie-Salpetriere

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Paris Cedex 10 : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Toulouse : Centre Hospitalo-Universitaire de Toulouse Purpan

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Toulouse Cedex : Institut Claudius Régaud

Patients are needed to participate in a clinical research study of CC-223

Villejuif : Department of Medical Oncology-Institut Gustave Roussy

A clinical trial to evaluate treatments using CC-115 for patients

Villejuif : Institut Gustave Roussy

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Villejuif Cedex : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Villejuif Cedex : Institut Gustave Roussy, Dept. of Medicine

Patients are needed to participate in a clinical research study of CC-223

Germany

Berlin : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Dresden : Universitatsklinikum Carl Gustav Carus

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

Hamburg : University Medical Center Hamburg-Eppendorf

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Heidelberg : University of Heidelberg

A Phase 1/Phase 2 clinical study for patients with Glioblastoma Multiforme

Heidelberg : Department of Neurosurgery, University Hospital Heidelberg

A Phase 1/Phase 2 clinical study for patients with Glioblastoma Multiforme

Heidelberg : Medical University Heidelberg

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Heidelberg : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Kiel : University Hospital of Schleswig-Holstein

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Koeln : Uniklinik Koln

A clinical trial to evaluate treatments using CC-115 for patients

Wuerzburg : Universitatsklinikum Wuerzburg

A clinical trial to evaluate treatments using CC-115 for patients

Israel

Tel Aviv : Tel Aviv Sourasky Medical Center

A clinical trial seeking patients for a research study for the treatment of Glioblastoma Multiforme

Tel Aviv : Tel Aviv Sourasky Medical Center

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Italy

Ancona : Az. Ospedaliero-Universitaria - Ospedali Riuniti

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Lecco : Ospedale Lecco

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Milan : Instituto Nazionale Tumori-via Venezian

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Milan : C. Besta Neurological Institute

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Milan : Foundation Hospital Greater Policlinico

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Milano : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Napoli : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Rome : Istituti Fisioterapici Ospitalieri - Istituto Nazionale dei Tumori Regina Elena

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Rozzano : Instituto clinic Humanitas

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Siena : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Korea, Republic of

Asan : Asan Medical Center

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Daegu : Yeungnam University Hospital

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Daejeon : Chungnam National University Hospital (CNUH)

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Seoul : Seoul National University Bundang Hospital (SNUBH)

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Seoul : Seoul National University Hospital (SNUH)

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Seoul : The Catholic University of Korea, Seoul St. Mary's Hospital (CMC Seoul)

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Seoul : Samsung Medical Center (SMC)

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Seoul : Yonsei University Severance Hospital (YUHS)

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Seoul : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Suwon : Ajou University Hospital (AUH)

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Netherlands

Rotterdam : Site Reference ID/Investigator# 92294

Patients are needed to participate in a clinical research study evaluating ABT-414, Temozolomide and Whole Brain Radiation for the treatment of Glioblastoma Multiforme

Spain

Badalona : Hospital Universitari Germans Trias i Pujol

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Barcelona : Hospital Universitario Vall Hebrón

A clinical trial to evaluate treatments using CC-115 for patients

Barcelona : Hospital Universitari Vall Hebrón

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Barcelona : Hospital del Mar

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Barcelona : Hospital Universitari de Bellvitge-ICO Duran i Reynals

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Barcelona : Hospital Clinic i Provincial de Barcelona

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Barcelona : Novartis Investigative Site

Patients are needed to participate in a clinical research study of BKM120 + temozolomide and BKM120 +temozolomide with/without radiotherapy to evaluate Glioblastoma

Madrid : Unidad de Fase I 3º planta Hospital Universitario Madrid Sanchinarro

A clinical trial to evaluate treatments using CC-115 for patients

Madrid : Hospital Universitario 12 de Octubre

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Madrid : Hospital Universitario Ramon y Cajal

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Madrid : Hospital 12 de Octubre, Servicio de Oncología Médica

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Madrid : Fundacion Jimenes Diaz

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Madrid : Hospital Clinico San Carlos

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Madrid : Novartis Investigative Site

Patients are needed to participate in a clinical research study of BKM120 + temozolomide and BKM120 +temozolomide with/without radiotherapy to evaluate Glioblastoma

Pamplona : Clinica Universidad de Navarra

A clinical trial seeking patients for a research study for the treatment of Glioblastoma Multiforme or Recurrent Tumor

Pamplona : Clínica Universidad de Navarra

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Salamanca : Hospital Universitario de Salamanca

Patients are needed to participate in a clinical research study of CC-223

San Sebastian : Hospital de Donosti

A clinical trial to evaluate treatments using CC-115 for patients

Sevilla : Pasillo Onco-Hematología. Sala de Protocolos Hospital Universitario Virgen del Rocío

A clinical trial to evaluate treatments using CC-115 for patients

Seville : Servicio de Oncologia Medica Sala de Investigación

Patients are needed to participate in a clinical research study of CC-223

Valencia : Hospital Universitario Clinco de Valencia

A Phase 1 clinical study for patients with Solid Tumors, Non-Hodgkin's Lymphoma or Multiple Myeloma

Sweden

Stockholm : Karolinska Institute

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Switzerland

Lausanne : Centre Hospitalier Universitaire Vaudois (CHUV)

A Phase 3 clinical study for patients with Glioblastoma Multiforme

Zurich : UniversitätsSpital Zürich

A Phase 3 clinical study for patients with Glioblastoma Multiforme

United Kingdom

London : King's College Hospital

Patients are needed to participate in a clinical research study evaluating Dendritic cell immunotherapy

London : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

London : University College London Hospitals NHS Foundation Trust

Patients are needed to participate in a clinical research study of CC-223

London : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study of CC-223

Northwood : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Oxford : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer

Sutton : Research Site

Patients are needed to participate in a clinical research study evaluating MEDI4736 for the treatment of Advanced Malignant Melanoma, Renal Cell Carcinoma, Non-small Cell Lung Cancer or Colorectal Cancer